Innovative Research Award
Louis Picker
Oregon Health & Science University
The Innovative Research Award recognizes scholarly contributions associated with significant and sustained research activity. This article presents an academic profile of Louis Picker of Oregon Health & Science University, with particular reference to research relevant to HIV cure strategies, scientific publications, citation performance, and the suitability of his research record for recognition through the International Research Awards on Infectious Diseases.[1]
Abstract
Louis Picker is a researcher at Oregon Health & Science University whose scholarly record is associated with major investigations in immunology, virology, vaccine science, and HIV cure research. His Scopus profile reports 257 documents, 37,921 citations, and an h-index of 90, indicating substantial publication visibility and long-term citation influence. This profile evaluates his research background, contributions, publication activity, research impact, and relevance to the Innovative Research Award within the International Research Awards on Infectious Diseases, using publicly presented academic metrics and representative scientific literature.[1]
Keywords
Innovative Research Award, Louis Picker, HIV cure, HIV immunology, infectious diseases, vaccine research, persistent viral infection, Scopus, research impact, Oregon Health & Science University.[1]
Introduction
Research on HIV continues to require advances in viral persistence, host immunity, prevention, therapeutic intervention, and cure-oriented strategies. Academic recognition in this field commonly considers sustained scientific productivity, influence on subsequent research, methodological development, and relevance to unresolved infectious disease challenges. Louis Picker’s publication record provides a basis for examining these criteria within an academic recognition context.[2]
Research Profile
Louis Picker is affiliated with Oregon Health & Science University in the United States. His research profile includes work relevant to viral immunology, T-cell biology, vaccine approaches, and persistent infections. The subject area identified for this article is HIV cure, reflecting research questions concerning durable immune responses and strategies directed toward controlling or eliminating persistent infection.[1]
Research Contributions
Research associated with Picker has examined unconventional immune mechanisms and the potential of cytomegalovirus-based vaccine vectors to generate distinctive cellular immune responses. Published studies have also investigated vaccine-mediated control of simian immunodeficiency virus, providing experimental evidence relevant to broader discussions of immune-based approaches to persistent viral infection and HIV cure research.[2]
Publications
The Scopus author record associated with Scopus ID 7005304033 reports 257 documents. This publication activity spans a substantial scholarly record and provides measurable evidence of continued research dissemination. Representative publications address vaccine vectors, cellular immunity, and persistent viral infection, including studies that have contributed to scientific discussion concerning immune-mediated control of lentiviral disease.[1][2]
Research Impact
The profile reports 37,921 citations and an h-index of 90, metrics that indicate broad citation activity across the research record. Citation indicators do not independently measure scientific quality or practical impact, but they provide one quantitative perspective on how frequently published work has been referenced within subsequent scholarship. These indicators support assessment alongside research relevance and documented contributions.[1]
Award Suitability
Based on the reported publication volume, citation record, h-index, institutional affiliation, and research relevance to HIV and infectious diseases, the profile presents characteristics consistent with consideration for the Innovative Research Award. The final suitability determination would depend on the award’s formal eligibility criteria, nomination materials, supporting evidence, and comparative evaluation procedures established by the event organizers.[3]
Conclusion
Louis Picker’s academic profile reflects sustained publication activity and substantial citation visibility in areas relevant to infectious disease and HIV research. His documented work on immunological mechanisms and vaccine-based approaches provides a scholarly basis for consideration within research recognition programs. The Innovative Research Award profile should be interpreted alongside formal verification and event-specific evaluation criteria.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Louis Picker, Author ID 7005304033. Scopus.
https://www.scopus.com/pages/authors/7005304033
- Grossman, Z., Meier-Schellersheim, M., Paul, W. E., & Picker, L. J. (n.d.). Pathogenesis of HIV infection: What the virus spares is as important as what it destroys.
https://www.nature.com/articles/nm1380
- Goldstein, L. A., Zhou, D. F. H., Picker, L. J., Minty, C. N., Bargatze, R. F., & Ding, J. F. (n.d.). A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins.
https://www.sciencedirect.com/science/article/abs/pii/0092867489906399